The Ejtm3 Editor-in-Chief is proud to announce that the SCOPUS Cite Score for the year 2020 is 2.1 (Calculated on 05 May, 2021 ) and that the CiteScoreTracker 2021 is 2.5 (Last updated on 04 June, 2021 - Updated monthly). He also invites Ejtm3 Authors and Readers to send him the Abstracts for Oral or Poster Presentations for the 2022 In-presence Padua Days of Muscle & Mobility Medicine (2022 In-presence PDM3), March 30th - April 1st - Deadline: September 30th, 2021. Send your Abstract, please to: email@example.comRead more about Scopus Cite Score Tracker of Ejtm3 increased to 2.5 - Calculated June 4, 2021
LETTERS TO THE EDITOR
I am proud to announce that are listed in PUBMED the papers of the European Journal of Translational Myology 30 (4), 2020 (PAGEPress: EJTM - SCOPUS Cite Score Tracker 2020 = 2.0).
Link to: PUBMED
Looking forward to your NEXT submission to EJTM and to your Abstracts for the 2021 Semi-Virtual Padua Days on Myology and Mobility Medicine - May 26-29 - Thermae of Euganean Hills, Padova (Italy)
Deadline: February 15, 2021 - 2021 PDM3 PROMO: VIDEO
Ugo Carraro, EJTM Editor-in-ChiefRead more about The papers of Ejtm 30 (4), 2020 are listed in PUBMED
COVID-19 infection is spreading and human victims and hospital costsRead more about Covid-19 and people with neuromuscular disorders: World Muscle Society position and advice
are growing. Although the incidence of genetic neuromuscular diseases
is low, screening procedures and new treatments have increased
prevalence and hospitalization. Here, Physicians of the World Muscle
Society recommend cautions about hospital and medical care.